UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
79 hedge funds and large institutions have $69.1M invested in Unity Biotechnology in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
35% less call options, than puts
Call options by funds: $462K | Put options by funds: $706K
68% less capital invested
Capital invested by funds: $216M → $69.1M (-$147M)
Holders
79
Holding in Top 10
2
Calls
$462K
Puts
$706K
Top Buyers
| 1 | +$1.02M | |
| 2 | +$573K | |
| 3 | +$311K | |
| 4 |
LPL Financial
San Diego,
California
|
+$222K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
+$209K |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$4.62M | |
| 3 | -$4.31M | |
| 4 |
IFA
Invus Financial Advisors
New York
|
-$3.79M |
| 5 |
Renaissance Technologies
New York
|
-$2.44M |